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Abstract
Background: Pericardial fat has adverse effects on the surrounding vasculature. Previous studies suggest that pericardial fat
may contribute to myocardial ischemia in symptomatic individuals. However, it is unknown if pericardial fat has similar
effects in asymptomatic individuals.
Methods: We determined the association between pericardial fat and myocardial blood flow (MBF) in 214 adults with no
prior history of cardiovascular disease from the Minnesota field center of the Multi-Ethnic Study of Atherosclerosis (43%
female, 56% Caucasian, 44% Hispanic). Pericardial fat volume was measured by computed tomography. MBF was measured
by MRI at rest and during adenosine-induced hyperemia. Myocardial perfusion reserve (PR) was calculated as the ratio of
hyperemic to resting MBF.
Results: Gender-stratified analyses revealed significant differences between men and women including less pericardial fat
(71.9631.3 vs. 105.2657.5 cm
3,p ,0.0001) and higher resting MBF (1.1260.23 vs. 0.9360.19 ml/min/g, p,0.0001),
hyperemic MBF (3.4960.76 vs. 2.6560.72 ml/min/g, p,0.0001), and PR (3.1960.78 vs. 2.9360.89, p=0.03) in women.
Correlations between pericardial fat and clinical and hemodynamic variables were stronger in women. In women only
(p=0.01 for gender interaction) higher pericardial fat was associated with higher resting MBF (p=0.008). However, this
association was attenuated after accounting for body mass index or rate-pressure product. There were no significant
associations between pericardial fat and hyperemic MBF or PR after multivariate adjustment in either gender. In logistic
regression analyses there was also no association between impaired coronary vasoreactivity, defined as having a PR ,2.5,
and pericardial fat in men (OR, 1.18; 95% CI, 0.82–1.70) or women (OR, 1.11; 95% CI, 0.68–1.82).
Conclusions: Our data fail to support an independent association between pericardial fat and myocardial perfusion in adults
without symptomatic cardiovascular disease. Nevertheless, these findings highlight potentially important differences
between asymptomatic and symptomatic individuals with respect to the underlying subclinical disease burden.
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Introduction
Visceral adiposity is a well-established risk factor for cardiovas-
cular morbidity and mortality [1]. Pericardial fat is a visceral fat
depot adjacent to the myocardium and coronary arteries that may
be particularly relevant for cardiovascular diseases [2]. We and
others have shown that pericardial fat is increased in coronary
artery disease (CAD) patients and is positively associated with
disease severity [3,4]. We also reported that higher pericardial fat
is associated with higher amounts of coronary calcium, even after
adjusting for total and abdominal obesity [5]. Given its close
proximity to the coronary arteries (,100 mm), as well as the
pericardial, pericardiophrenic, and musculophrenic arteries, it is
thought that pericardial fat interacts with neighboring cells
through the release of bioactive factors [6]. Indeed, pericardial
fat around the coronary arteries has been shown to express
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and monocyte chemoattractant protein-1, but low levels of
adiponectin [7,8]. This heightened pro-inflammatory state may
promote endothelial dysfunction and vascular remodeling [9,10].
Moreover, increased adiponectin levels in the coronary circulation
have been associated with a greater coronary vasodilatory
response [11]. Taken together, these data suggest that pericardial
fat may have both direct and indirect effects on vascular structure
and function.
Very few studies have explored the in vivo relationship between
coronary vasodilatory function and pericardial fat. In the clinical
setting, the measurement of blood flow through the coronary
arteries (i.e. myocardial perfusion) by non-invasive imaging is often
used to assess coronary vasoreactivity [12]. Recently, Tamarappoo
et al. reported that among individuals without known CAD,
pericardial fat volume was 22% higher in those with myocardial
ischemia compared to non-ischemic controls [13]. The study
population included both symptomatic and asymptomatic indi-
viduals. Other studies in adults with chest pain have found similar
relationships between cardiac obesity and myocardial perfusion
[14,15]. However, based on the literature to date, it is unclear if
pericardial fat adversely affects the coronary microcirculation in
asymptomatic individuals. Thus, the purpose of this study was to
investigate the association between pericardial fat and myocardial
perfusion in asymptomatic adults free of cardiovascular disease
from the Multi-Ethnic Study of Atherosclerosis (MESA). As
coronary vasoreactivity may be impaired early in the atheroscle-
rotic process, even in the absence of ischemic symptoms [12],
asymptomatic persons likely have a different subclinical disease
burden compared to symptomatic persons. We previously
reported that a number of CAD risk factors, including older age,
male gender, elevated blood pressure, and high cholesterol levels,
are associated with coronary vascular dysfunction in the MESA
cohort, as evidenced by lower myocardial blood flow (MBF) and/
or myocardial perfusion reserve (PR) [16,17]. In the present
analysis, we hypothesized that impaired coronary vasoreactivity
would also be associated with a higher pericardial fat volume in
this asymptomatic population.
Materials and Methods
Ethics Statement
Institutional Review Board approval was obtained at all MESA
sites (Northwestern University, Wake Forest University, Johns
Hopkins University, Columbia University, University of Minne-
sota, and UCLA). All study procedures were in accordance with
institutional guidelines, and all participants provided written
informed consent.
Study Population. MESA is a prospective community-based
cohort study of 6,814 men and women aged 45 to 84 years from
four different ethnic groups (Caucasian, African American,
Hispanic, and Chinese) [18]. Participants were recruited
between July 2000 and September 2002 from six field centers
including Forsyth County, NC; Northern Manhattan and the
Bronx, NY; Baltimore City and Baltimore County, MD; St. Paul,
MN; Chicago, IL; and Los Angeles County, CA. Individuals were
excluded if they had physician-diagnosed heart attack, angina,
stroke, transient ischemic attack, heart failure, or atrial fibrillation;
were taking nitroglycerin; or had undergone coronary artery
bypass grafting, angioplasty, valve replacement, pacemaker or
defibrillator implantation, or any surgery on the heart or arteries.
Each participant at the Minnesota field center (n=1,066) was
contacted for a perfusion study either immediately after the
baseline MESA exam or later by mail. Of those, 234 agreed to
participate. The present analysis is based on data from 214
participants after excluding those with missing data for MBF (n=5)
or pericardial fat (n=8) and those who took caffeine within
12 hours of the MRI examination (n=7). Except for a lower
prevalence of hypertension (29.9% vs. 38.5%), this subset had
similar characteristics to the individuals who declined to participate
in the perfusion study or were excluded from the analyses.
Pericardial Fat. Pericardial fat volume was measured from
computed tomography (CT) scans performed at the baseline
MESA exam [5]. Our measurement of pericardial fat includes
both epicardial fat (located within the pericardium) and
paracardial fat (located superficial to the pericardium). We and
others have shown an excellent correlation between pericardial
and epicardial fat depots (r=0.92 and 0.97, respectively) [4,19].
Given the lower reproducibility of epicardial fat measurements
[19,20] and the difficulty in visualizing the pericardium,
particularly over the left ventricle [21], we chose to measure
only pericardial fat for these analyses. Segmentation was achieved
by isolating pericardial fat and heart from the thorax using specific
anatomic landmarks. The anterior border of the volume was
defined by the chest wall and the posterior border by the aorta and
the bronchus. Slices within 15 mm above and 30 mm below the
superior extent of the left main coronary artery (a total of 19 slices)
were included in the analysis. This region of the heart was selected
because it includes the pericardial fat located specifically around
the proximal coronary arteries (left main coronary, left anterior
descending, right coronary, and circumflex arteries). Volume
Analysis software (GE Healthcare, Waukesha, WI) was used to
discern fat from the remaining portions of the heart with a
threshold of 2190 to 230 Hounsfield units. The volume was the
sum of all voxels containing pericardial fat. Intra-class correlation
coefficients for inter-reader and intra-reader reliability are 0.997
and 0.999, respectively [5]. This measurement is highly correlated
with the ‘‘gold standard’’ method (r=0.93) which measures the
total volume of pericardial fat encasing the heart and takes about
half the time to complete [5]. Pericardial fat was assessed as the
total absolute volume and indexed to left ventricular mass (i.e.
pericardial fat index).
MRI Perfusion Study. Cardiac MRI was performed with a
1.5-T clinical MR scanner (Sonata, Siemens Medical Systems,
Iselin, New Jersey) an average of 334 days (range: 20–645) after
the baseline examination. Participants were asked to refrain from
caffeine for 12 hours before this visit. During the exam,
participants were positioned supine with a flexible, four-element
phased-array coil placed over their heart, with two elements of a
spine array coil serving as posterior antennae. Starting at the third
or fourth heartbeat, 0.04 mmol/kg body weight of a Gd-DTPA
contrast agent (Magnevist, Berlex, Wayne, NJ) was administered
intravenously at a rate of 7 ml/s. T1-weighted gradient-echo
imaging of 2 to 3 adjacent left ventricle slices in the short axis
orientation, with a nonslice-selective saturation recovery
magnetization preparation, was used to visualize the first pass of
the injected contrast bolus through the heart, as previously
described [22]. To induce vasodilation, 0.14 mg/kg/min of
adenosine was infused intravenously for 3 minutes before the
start of the scan, blocked for approximately 3 seconds during MR
contrast injection, resumed immediately thereafter, and then
discontinued 10 to 15 seconds after starting the perfusion scan. A
first perfusion scan was performed at rest, followed by a second
scan approximately 15 minutes later during maximal vasodilation.
Blood pressure, heart rate, and an electrocardiogram were
monitored and recorded during the exam. Rate-pressure
product (RPP) was calculated as the product of heart rate and
systolic blood pressure divided by 10,000.
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and epicardial contours were manually traced. The myocardium
was subdivided into eight transmural sectors of equal
circumferential extent along the myocardial centerline. Region-
of-interest signal intensity curves were generated with the MASS
CMR image analysis software (Laboratory for Clinical and
Experimental Image Processing, Leiden University, The
Netherlands). These curves represent the change of mean signal
intensity as a function of time, corrected for baseline- and coil-
sensitivity variations. In accordance with the central volume
principle [23], MBF (in ml/min/g) was estimated from the initial
amplitude of the myocardial impulse response by deconvolution
analysis of the myocardial signal intensity curves. Custom-written
software was used to perform a model-independent deconvolution
of the signal intensity curves, with an arterial input measured in
the center of the left ventricle. As described and validated
previously, MBF estimation by this method is highly correlated
with measurements using radioisotope-labeled microspheres
(R
2=0.995), which is the gold-standard in MBF quantification
[24–26]. All MBF measurements are reported as global averages
over the eight myocardial segments and two to three slices. The
intra-class correlation for duplicate global MBF measurements
taken ,1 year apart are 0.65 for resting MBF and 0.71 for
hyperemic MBF [22]. Myocardial PR was calculated as the ratio
of hyperemic to resting MBF. An index of coronary vascular
resistance (CVR) was calculated as mean arterial pressure divided
by MBF.
Clinical Variables from the Baseline MESA Exam. Stand-
ard questionnaires were used to collect information on
demographics, smoking, comorbidities, and medications. Height
and weight were measured and body mass index (BMI) was
calculatedasheightdividedbyweightsquared.Waistcircumference
(at the umbilicus) and hip circumference (at the maximum
circumference of the buttocks) were measured using a Gulick II
measuring tape. Seated blood pressure was measured in the right
arm after five minutes of rest using a Dinamap model Pro 100
automated oscillometric sphygmomanometer (Critikon, Tampa,
FL). Hypertension was defined as systolic blood pressure
$140 mmHg, diastolic blood pressure $90 mmHg, self-reported
history of hypertension, or current use of anti-hypertensive
medications. Diabetes was defined as fasting glucose $126 mg/dl,
self-reported history of diabetes, or current use of diabetes
medications. Fasting blood samples were analyzed at a central
laboratory using standard methods to determine low-density
lipoprotein (LDL) and high-density-lipoprotein (HDL) cholesterol.
C-reactive protein was measured using the BNII nephelometer
(Dade Behring Inc, Deerfield, IL). Coronary calcium was measured
by electron-beam or four-detector row CT, as previously described
[27]. The amount of calcium averaged from two consecutive scans
was quantified using the Agatston scoring method [28]. Left
ventricular mass was determined by volumetric imaging [29].
Statistical Analysis. All statistical analyses were performed
using SAS software version 9.1 (SAS Institute, Cary, NC). Chi-
square tests and analysis of variance were used to determine
differences in categorical and continuous variables, respectively.
Spearman correlation coefficients were used to describe the
relationship of pericardial fat with clinical and hemodynamic
variables. Linear regression was used to determine the relationship
of pericardial fat with resting MBF, hyperemic MBF, and PR. We
also modeled hyperemic MBF with adjustment for resting MBF as
an alternative interpretation of PR. Covariates were included
based on univariate associations with pericardial fat and/or
previously documented associations with MBF variables in this
population [16,17]. Interaction terms were examined to determine
whether the associations with MBF measures were modified by
gender or race/ethnicity. There was a significant gender
interaction for resting MBF (p=0.001), but not hyperemic MBF
(p=0.37) or PR (p=0.13). There were no interactions with race/
ethnicity (p.0.10). Based on these findings, gender-stratified
models were adjusted for age, race/ethnicity, education, smoking,
LDL and HDL cholesterol, statins, hormone replacement therapy
(HRT, in women only), C-reactive protein, diabetes, diastolic
blood pressure, anti-hypertensive medications, and coronary
calcium. The presence of coronary calcium was defined as an
Agatston score .0; however, we also considered scores $100 and
$400. To determine if the associations were independent of
obesity or cardiac work, we additionally adjusted for BMI, waist
circumference, waist-to-hip ratio, and RPP, in separate models.
Logistic regression was used to estimate odds ratios (OR) and 95%
confidence intervals (CI) for a reduced PR, defined as ,2.5
[30,31]. Associations with MBF measures are reported per 1-
standard deviation (SD) increment in pericardial fat (57.5 cm
3 for
men and 31.3 cm
3 for women). Statistical significance was set at
p#0.05.
Results
Participant Characteristics
Participant characteristics by gender are shown in Table 1. The
prevalences of diabetes (p=0.04) and coronary calcium (p=
0.0002) were higher in men compared to women, while more
women had abdominal obesity (45% vs. 72% based on a waist
circumference .88 cm in women and .102 cm in men,
p,0.0001) and reported smoking ,100 cigarettes in their lifetime
(p=0.04). Women had a lower waist circumference, waist-to-hip
ratio, left ventricular mass, and diastolic blood pressure than men,
but higher HDL cholesterol and C-reactive protein (p,0.0001 for
all). Women also had less pericardial fat than men (p,0.0001), but
not after normalizing to left ventricular mass (p=0.28). MBF and
CVR at rest and during hyperemia (p,0.0001 for all), as well as
PR (p=0.03) were higher in women.
Associations with Pericardial Fat
Pericardial fat was higher in obese (BMI$30 kg/m
2) vs. non-
obese men (141.5662.8 cm
3 vs. 83.7641.4 cm
3,p ,0.0001) and
women (91.6631.3 cm
3 vs. 58.9623.7 cm
3,p ,0.0001). Pericar-
dial fat was also higher in men and women with abdominal obesity
(134.8664.2 cm
3 and 81.4630.1 cm
3, respectively) compared to
those without (81.4637.4 cm
3 and 44.8614.3 cm
3, respectively,
p,0.0001 for both). These differences remained after normalizing
pericardial fat to left ventricular mass (p,0.01 for all). In both men
and women, pericardial fat was positively associated with age, C-
reactive protein, BMI, waist circumference, waist-to-hip ratio,
heart rate, and resting RPP, and inversely associated with HDL
cholesterol (Table 2). In women only, pericardial fat was also
positively associated with blood pressure, left ventricular mass,
resting MBF, and hyperemic RPP and inversely associated with
PR. There were no significant associations between pericardial fat
and LDL cholesterol, coronary calcium, CVR, or hyperemic MBF
in either gender.
Pericardial Fat and MBF
In models adjusted for age, race/ethnicity, education, smoking,
LDL and HDL cholesterol, statins, HRT, C-reactive protein,
diabetes, diastolic blood pressure, anti-hypertensive medications,
and coronary calcium, pericardial fat (per 1-SD increment)
was positively associated with resting MBF in women
(b=0.08360.031, p=0.008, Table 3), but not in men
Pericardial Fat and Myocardial Perfusion
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interaction). Pericardial fat remained associated with resting MBF
in women after further adjusting for waist circumference (p=0.03)
or waist-to-hip ratio (p=0.01); however, additional adjustment for
BMI (p=0.12) or resting RPP (p=0.07) attenuated this associa-
tion. Pericardial fat was not associated with hyperemic MBF
in neither men (b=0.04260.073, p=0.56) nor women
(b=0.06760.105, p=0.52). Results were similar with and without
adjustment for resting MBF. There was also no significant
association between pericardial fat and PR in men
(b=20.00260.088, p=0.98), while the association in women
approached significance (b=20.14760.094, p=0.12). Using
more stringent criteria to define the presence of coronary calcium
(,100 vs. $100 or ,400 vs. $400) had no major effect on the
results (data not shown).
Pericardial Fat and Reduced PR
The prevalence of a reduced PR (,2.5) was 2-fold greater in
men compared to women (40.5% vs. 20.4%, p=0.002).
Pericardial fat averaged 110.868.2 cm
3 and 101.466.3 cm
3 in
men (p=0.38) and 74.667.2 cm
3 and 71.363.7 cm
3 in women
(p=0.68) with and without a reduced PR, respectively, as shown
in Figure 1. Logistic regression analyses revealed no association
between a 1-SD unit increment in pericardial fat and a reduced
PR in men (OR, 1.18; 95% CI, 0.82–1.70) or women (OR, 1.11;
95% CI, 0.68–1.82).
Discussion
We investigated whether pericardial fat is adversely related to
myocardial perfusion in asymptomatic adults with no prior history
of cardiovascular disease. The main finding of this study was that
pericardial fat is not associated with coronary vasoreactivity. The
lack of a significant relationship between pericardial fat and both
hyperemic MBF and PR was surprising given that inverse
associations have been found with cardiac obesity in symptomatic
Table 1. Participant characteristics.
Characteristic Men (n=121) Women (n=93)
Age (yrs) 60.4610.4 59.5610.3
Hispanic (%) 47.9 37.8
Education
High school diploma or GED 34.7 41.9
Some college or technical school 35.5 30.1
Bachelor’s or graduate degree 29.8 28.0
Smoking status (%)
Never 33.1 48.4*
Former 51.2 34.4
Current 15.7 17.2
Diabetes (%) 14.1 5.4*
Hypertension (%) 31.4 28.0
Coronary calcium score (%)
0 34.7 62.4*
0.01–99 28.9 23.7
100–399 19.0 8.6
$400 17.4 5.4
Systolic blood pressure (mmHg) 122615 119622
Diastolic blood pressure (mmHg) 75686 5 610
{
Heart rate (beats/min) 62610 6369
HRT use (%) — 43.0
Statin use (%) 14.9 11.8
HDL cholesterol (mg/dl) 43.6611.9 53.9612.8
{
LDL cholesterol (mg/dl) 120.5628.2 115.2628.3
C-reactive protein (mg/l) 1.42 (0.70–2.96) 2.99 (1.43–7.24)
{
BMI (kg/m
2) 28.864.2 28.965.4
Waist circumference (cm) 100.8611.5 97.2614.1
{
Waist-to-hip ratio 0.09760.064 0.09060.073
{
Pericardial fat (cm
3) 105.2657.5 71.9631.3
{
Pericardial fat index (cm
3/g) 0.5960.32 0.5560.23
Left ventricular mass (g) 183.2635.3 132.0629.0
{
Resting MBF (ml/min/g) 0.9360.19 1.1260.23
{
Hyperemic MBF (ml/min/g) 2.6560.72 3.4960.76
{
Perfusion reserve 2.9360.89 3.1960.78*
Resting RPP (beats/min mmHg) 0.9060.17 0.9260.25
Hyperemic RPP (beats/min mmHg) 1.0660.23 1.1260.30
Resting CVR (mmHg/ml/min/g) 110.98623.00 85.73616.85
{
Hyperemic CVR (mmHg/ml/min/g) 37.85612.33 27.1169.85
{
Table values are mean 6 SD or median (interquartile range). Significant gender
difference,
*p,0.05,
{p,0.0001.
BMI=body mass index; CVR=coronary vascular resistance; HRT=hormone
replacement therapy; HDL=high-density lipoprotein; LDL=low-density
lipoprotein; MBF=myocardial blood flow; RPP=rate-pressure product.
doi:10.1371/journal.pone.0028410.t001
Table 2. Association between clinical and hemodynamic
characteristics and pericardial fat.
Characteristic Men (n=121) Women (n=93)
Age (yrs) 0.23* 0.26*
Systolic blood pressure (mmHg) 0.13 0.48
{
Diastolic blood pressure (mmHg) 0.12 0.24*
HDL cholesterol (mg/dl) 20.42
{ 20.41
{
LDL cholesterol (mg/dl) 0.04 20.05
Heart rate (beats/min) 0.44
{ 0.31*
C-reactive protein (mg/l) 0.37
{ 0.33*
Coronary calcium score 0.17 0.02
BMI (kg/m
2) 0.60
{ 0.64
{
Waist circumference (cm) 0.57
{ 0.65
{
Waist-to-hip ratio 0.61
{ 0.47
{
Left ventricular mass (g) 0.14 0.33*
Resting MBF (ml/min/g) 0.05 0.29*
Hyperemic MBF (ml/min/g) 20.06 0.13
Perfusion Reserve 20.10 20.21*
Resting RPP (beats/min mmHg) 0.21* 0.37*
Hyperemic RPP (beats/min mmHg) 0.05 0.25*
Resting CVR (mmHg/ml/min/g) 20.01 20.16
Hyperemic CVR (mmHg/ml/min/g) 0.07 0.02
Table values are Spearman correlation coefficients (r).
*p,0.05,
{p#0.0001;
Abbreviations as in Table 1.
doi:10.1371/journal.pone.0028410.t002
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pericardial fat and higher resting MBF in women; however, this
association was attenuated after further adjustment for BMI or
RPP. Thus, our data fail to support an independent association
between pericardial fat and myocardial perfusion in this
population.
Previous studies investigating the association between cardiac
obesity and myocardial perfusion have predominately included
symptomatic individuals. Sade et al. reported that among women
with angiographically normal coronary arteries, those with an
impaired PR had 38% greater epicardial fat thickness on the free
wall of the right ventricle than women with a normal PR [15].
However, measurements of epicardial fat thickness at a single
point are highly dependent on cardiac anatomy and fat
distribution [32] and do not correlate well with either epicardial
or pericardial fat volume [20]. More recently, Bucci et al. found
that among patients with obstructive CAD, epicardial fat volume
was roughly 20% higher in those with a hyperemic MBF value
below vs. above the median (#1.75 ml/min/g) [14]. Additionally,
higher epicardial fat was an independent predictor of lower
hyperemic MBF and PR in multiple regression analyses. Janik et
al. also reported that among patients presenting with angina and
no prior cardiovascular disease, individuals with mild-to-severe
ischemia had 38% higher epicardial fat volume compared to those
with no ischemia [33]. In a similar study that included adults with
and without symptoms, Tamarappoo et al. reported 22% higher
pericardial fat volume and 24% higher epicardial fat volume in
patients with ischemia compared to non-ischemic controls [13].
Although the proportion of asymptomatic individuals was fairly
similar between cases and controls (63% vs. 54%, respectively), the
presence of symptoms was one of the strongest predictors of
prevalent ischemia in multivariable analyses, second only to
epicardial/pericardial fat volume.
In contrast to the study by Tamarappoo et al., we were unable
to find a significant association between pericardial fat and
myocardial ischemia. In fact, pericardial fat was only 9% and 5%
higher in men and women, respectively, with impaired PR
compared to those with a normal PR. In addition, although we
observed a significant correlation between higher pericardial fat
and lower PR (in women only), this association was attenuated
after adjusting for other risk factors. As such, these data suggest
that pericardial fat does not have independent effects on
myocardial perfusion in asymptomatic adults. Moreover, our
findings highlight potentially important distinctions between
asymptomatic and symptomatic persons with respect to subclinical
atherosclerosis. For example, in the study by Tamarappoo et al.,
approximately 91% of the population had moderate-to-severe
atherosclerosis as evidenced by coronary calcium scores $100
[13]. On the other hand, only 26% of our study participants had
coronary calcium scores $100, with nearly half having no
coronary calcium present at all. High coronary calcium scores
are associated with a higher likelihood of significant coronary
stenosis, whereas the absence of coronary calcium is associated
with a very low likelihood of obstructive CAD [34,35]. Moreover,
symptomatic CAD patients with elevated coronary calcium scores
have more severe stenosis than asymptomatic CAD patients with
similar calcium scores [36], suggesting that the presence of
symptoms does indeed reflect the underlying pathology, and likely
the patient profile. In this regard, the prevalence of impaired
coronary vasoreactivity (as defined using a lower cut-off value of
PR,2.0) was very low in our women (6%), compared to those in
the study by Sade et al. (40%). Furthermore, while the majority of
our participants had a low-to-medium 10-year CAD risk
(Framingham risk score=8%), Tamarappoo et al. and Janik et
al. investigated persons with Framingham risk scores of ,12–14%
[13,33].
Obesity-related cardiovascular disease may be partially caused
by altered adipokine-mediated signaling between local fat depots
and the adjacent blood vessels and cardiomyocytes [37].
Epicardial fat has a high expression of chemokines and
inflammatory cytokines [8], and increased periaortic fat in aging
and obesity promotes vascular smooth muscle cell growth [9].
Thus, in the presence of excess fat, these pro-inflammatory
activities are likely to be increased and thereby promote the
development of vascular dysfunction and atherosclerosis. Consis-
tent with this, Bucci et al. reported that among patients with CAD,
only those with significant flow-limiting stenosis had increased
epicardial fat volume, which suggests that in our population the
combination of CAD and increased pericardial fat may promote
impaired coronary vascular function, while CAD plus low/normal
pericardial fat may not. Although we do not have direct measures
of CAD, we did find that the prevalence of a reduced PR was 48%
in participants with coronary calcium present and pericardial fat
volume in the highest quartile ($130.5 cm
3 in men, $91.2 cm
3 in
women), while the prevalence was only 15% in participants with
no coronary calcium and pericardial fat in the lowest quartile
(,64.0 cm
3 in men, ,47.6 cm
3 in women). We also found
positive associations between pericardial fat and C-reactive
protein, age, blood pressure, HDL cholesterol, BMI, waist
circumference, and left ventricular mass in this study, which
confirms previous findings in the Framingham Heart Study [38].
Although a significant univariate association was found between
pericardial fat and resting MBF in women, adjusting for BMI
attenuated this relationship. Resting RPP (an indicator of cardiac
work) also appeared to be an important determinant of resting
Table 3. Association between MBF measures and pericardial
fat after multivariate adjustment.
Model Men (n=121) Women (n=93)
b±SE P-value b±SE P-value
Resting MBF (ml/min/g)
a 0.01660.021 0.46 0.08360.031 0.008
Plus BMI 0.03060.025 0.23 0.05960.037 0.12
Plus waist circumference 0.02460.024 0.31 0.07460.034 0.03
Plus waist-to-hip ratio 0.02460.024 0.33 0.08160.031 0.01
Plus resting RPP 20.01360.018 0.47 0.04460.024 0.07
Hyperemic MBF (ml/min/g)
a 0.04260.073 0.56 0.06760.105 0.52
Plus BMI 0.06260.070 0.38 0.07060.127 0.58
Plus waist circumference 0.06960.084 0.42 0.09060.119 0.45
Plus waist-to-hip ratio 0.00560.081 0.95 0.06260.108 0.56
Plus hyperemic RPP 0.02960.070 0.68 20.01360.101 0.89
Perfusion Reserve
a 20.00260.088 0.98 20.14760.094 0.12
Plus BMI 20.01960.102 0.85 20.04060.112 0.72
Plus waist circumference 20.03360.098 0.74 20.08660.106 0.45
Plus waist-to-hip ratio 20.05660.099 0.57 20.14660.097 0.14
Plus hyperemic RPP 20.000460.089 1.00 20.16260.098 0.10
Table values are regression coefficients (b) 6 standard errors (SE) per 1-SD unit
increment in pericardial fat: 57.5 cm
3 in men and 31.3 cm
3 in women.
aModel is adjusted for age, race/ethnicity, education, smoking, LDL and HDL
cholesterol, statins, diastolic blood pressure, anti-hypertensive medications,
HRT (in women), C-reactive protein, diabetes, and coronary calcium.
Abbreviations as in Table 1.
doi:10.1371/journal.pone.0028410.t003
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pericardial fat and resting MBF. It is important to remember that
our measurement of pericardial fat reflects both the direct
paracrine effects of epicardial fat on the coronary arteries, as well
as the indirect systemic effects of thoracic visceral fat (i.e.
paracardial fat) on metabolic risk factors [39]. Thus, taken
together, these data suggest that in asymptomatic individuals,
global obesity may have a greater influence on coronary
vasoreactivity than cardiac obesity.
There are a few limitations in this study. The sample size was
relatively small, which may have limited our ability to detect
associations in men vs. women. Although gender differences in the
prevalence and severity of cardiovascular diseases are well-
documented, the impact of gender on obesity-related changes in
MBF requires further study. In addition, our investigation was
limited to cross-sectional analyses, which cannot determine
whether increased pericardial fat precedes coronary vascular
dysfunction. Similarly, our assessment of abdominal obesity was
limited to anthropometric measures that cannot distinguish
between visceral and subcutaneous fat. Without direct measures
of total and abdominal fat, however, the relative importance of
pericardial fat remains to be elucidated. We also cannot rule out
the possibility that our participant subset is not completely
representative of or generalizable to the larger MESA population,
nor can we confirm the absence of obstructive atherosclerotic
lesions since our participants did not undergo coronary angiog-
raphy. Finally, although the myocardial perfusion measurements
are fairly reproducible, the variability of the hyperemic MBF
response over 1 year (absolute repeatability coefficient=1.19 ml/
min/g) has been shown to increase with the length of time between
baseline and follow-up measurements [22]. This bias may
underestimate the true variability in hyperemic MBF over longer
periods of time, which is important to know for prospective
population-based studies designed to assess the influence of risk
factors on disease incidence and progression.
In conclusion, pericardial fat is not independently associated
with hyperemic MBF or PR in asymptomatic men and women
with no prior history of cardiovascular disease. These results are in
contrast to a previous study in predominately symptomatic adults.
Despite the present negative findings, our study provides some
insight into the relationship among pericardial fat, atherosclerosis,
and MBF in asymptomatic vs. symptomatic individuals. In this
regard, it seems plausible that individuals with and without
ischemic symptoms may have a different subclinical atheroscle-
rotic disease burden, which may influence the effect of pericardial
fat on coronary microvascular function. These differences may
Figure 1. Pericardial fat in men and women with normal PR $2.5 and reduced PR ,2.5.
doi:10.1371/journal.pone.0028410.g001
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tion in asymptomatic populations. Given the growing evidence
that pericardial fat may be an important therapeutic target in the
prevention of CAD [4,5], further research in this area is
warranted.
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